Trading a IBB straddle lets you take a pure volatility position on iShares Biotechnology ETF without committing to a direction. iShares Biotechnology ETF's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate IBB straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on IBB profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when iShares Biotechnology ETF stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the IBB straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the IBB straddle is the cleanest expression of that view. Our scanner prices every IBB straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a IBB straddle into a catalyst or short a IBB straddle to harvest decay, the options straddle setups that matter are all in one place.
